Prime Therapeutics LLC

04/21/2026 | Press release | Archived content

AMCP 2026: Clinical, health outcomes research helps guide treatment strategy for health care payers, providers and patients

Every year, Prime Therapeutics (Prime) researchers and industry experts gather at the Academy of Managed Care Pharmacy (AMCP) annual meeting to present some of the latest data and insights transforming health care. At the latest conference in Nashville, Tennessee, Prime experts presented 10 research posters and seven educational sessions about topics including medical and pharmacy benefit integration, cost and utilization trends of new therapies, the impact of managed care pharmacist outreach, mental health parity, artificial intelligence and so much more.

These insights are foundational to how Prime delivers value to health care payers. Using evidence-driven expertise on how therapies are used, where gaps exist and which patients benefit most from additional support, Prime translates research into smarter clinical strategies and high-touch support for patients.

In the latest episode of the "Pharmacy Friends" podcast, "On the road at AMCP Annual 2026: Innovative research and expert insights drive breakthroughs in health outcomes," join host Alex Cook, senior public relations manager, and Prime experts who presented at AMCP 2026, for a discussion on how real-world medical and pharmacy data, pharmacist-led outreach and benefit integration are shaping smarter management of total costs. Guests include:

  • Marci Chodroff, M.D., vice president, medical director
  • Samantha Decker, PharmD, medical pharmacy clinical pharmacist
  • Nick Friedlander, PharmD, senior health outcomes researcher
  • Tim Heuring, PharmD, clinical account director
  • Alina Liang, PharmD, clinical pharmacist project director
  • Jacinda Tran, PharmD, Ph.D., senior health outcomes researcher
  • Ben Urick, PharmD, Ph.D., senior director, health outcomes

Topics covered in this episode include:

  • Why real-time evidence matters.
  • Coverage decisions benefit from "unpacking the data" with clients.
  • High-touch pharmacist-to-prescriber outreach helps deliver hard-dollar savings.
  • Rare disease insight and reinforcing the need for individualized management and payer case-management opportunities.
  • Integration signal by highlighting the value of coordinated care.

Listen to the latest "Pharmacy Friends" podcast episode

Check out other episodes of the podcast

Read more of the key insights from AMCP

Prime Therapeutics LLC published this content on April 21, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 07, 2026 at 13:33 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]